Total Funding
61
58
Total FundingSeries B raised
Growth Score
-9 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26566
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
- Jorge A. Quiroz: Executive Vice President & Chief Medical Officer
- Ana de Vera: CMOPast Role: Santhera Pharmaceuticals, Head of Development and Deputy CMO
About the Company
NMD Pharma is a clinical-stage biotech company that delivers life-transforming therapies for people living with neuromuscular diseases. They use ClC-1 Cl- ion channel inhibitors to treat neuromuscular diseases. Their translational muscle electrophysiology platform leverages in-depth knowledge of muscle physiology and muscular disorders to identify
and develop first-class therapeutics for neuromuscular diseases that are unmet medically.
